Mediamedic/LinkedIn
Sep 30, 2025, 16:12
Professor Ma Jun Will Highlight the 120-Year Legacy of Chinese Hematology
Mediamedic shared a post on LinkedIn:
“CSCO 2025 | Professor Ma Jun: 120 Years of Chinese Hematology Setting a Global Benchmark
The 28th CSCO Annual Meeting (September 10–14, 2025, Jinan) will gather world-leading oncology experts under the theme “Standardized Diagnosis and Treatment, Innovation-Driven Progress.”
Professor Ma Jun will highlight the 120-year legacy of Chinese hematology, showcasing its global impact and decoding the latest innovative therapies and breakthroughs that are shaping the future of cancer care.”
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 14:46A Behcet Disease with Aortic Thrombosis: Alexandru Stieber Shares A Peculiar Case
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies